CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment

Published:2022-12 Issue: Volume:245 Page:109158
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Li Fei,Qi Bing,Yang Le,Wang Bao,Gao Li,Zhao Minggao,Luo Lanxin

Funder

Young Scientists Fund

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

2. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014;Ostrom;Neuro-Oncology,2017

3. Glioblastoma multiforme, diagnosis and treatment; recent literature review;Batash;Curr. Med. Chem.,2017

4. Emerging treatment strategies for glioblastoma multiforme;Carlsson;EMBO Mol. Med.,2014

5. Current challenges in designing GBM trials for immunotherapy;Weathers;J. Neuro-Oncol.,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A humanized Anti-YKL-40 antibody inhibits tumor development;Biochemical Pharmacology;2024-07

2. Glutamine Metabolism Heterogeneity in Glioblastoma Unveils an Innovative Combination Therapy Strategy;Journal of Molecular Neuroscience;2024-05-10

3. Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes;Neuro-Oncology;2024-01-25

4. The genes significantly associated with an improved prognosis and long-term survival of glioblastoma;PLOS ONE;2023-11-29

5. Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy;Frontiers in Immunology;2023-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3